Home/Filings/4/0000899243-19-008359
4//SEC Filing

Marrazzo Jeffrey D 4

Accession 0000899243-19-008359

CIK 0001609351other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 5:26 PM ET

Size

7.1 KB

Accession

0000899243-19-008359

Insider Transaction Report

Form 4
Period: 2019-03-15
Marrazzo Jeffrey D
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-03-15$3.45/sh+49,940$172,293355,215 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-03-1549,940126,131 total
    Exercise: $3.45Exp: 2024-07-01Common Stock (49,940 underlying)
Footnotes (1)
  • [F1]This option was granted on July 2, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter.

Issuer

Spark Therapeutics, Inc.

CIK 0001609351

Entity typeother

Related Parties

1
  • filerCIK 0001631262

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:26 PM ET
Size
7.1 KB